Diabetic Neuropathy Market Report

Global and Region Diabetic Neuropathy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：178
  • REPORT CODE：GMM978173
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Growth in global diabetic neuropathy market is highly attributed to consistently increasing diabetic population across the globe linked with growing awareness among people is considered as major market driver for diabetic neuropathy market. Moreover, global market is primarily driven by changing lifestyle which has mostly resulted into unhealthy dietary habits and patterns. In addition, factors such as increasing aging population, rise in healthcare expenditure for diabetes, growing awareness about diabetes, and rise in R&D activities in drug discovery and development have contributed in the global growth. However, growth of this market is predominantly restrained by longer approval time for drugs and side effects and rising cost of diabetic neuropathy treatment. Also, stringent regulatory requirement and significant failure rate during the clinical trials expected to be the growth barriers in the years to come.

    The report details the trend, potential and market size of Diabetic Neuropathy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Diabetic Neuropathymarket, defines the market attractiveness level of Diabetic Neuropathy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Diabetic Neuropathy industry, describes the types of Diabetic Neuropathy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diabetic Neuropathy market and the development prospects and opportunities of Diabetic Neuropathy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diabetic Neuropathy market in Chapter 13.

    By Player:

    • Eli Lilly and Company

    • Pfizer Inc

    • NeuroMetrix

    • Cephalon Inc

    • Janssen Pharmaceuticals, Inc

    • GlaxoSmithKline

    • ACTAVIS

    • Johnson and Johnson

    By Type:

    • Peripheral Neuropathy

    • Autonomic Neuropathy

    • Proximal Neuropathy

    • Focal Neuropathy

    By End-User:

    • Hospitals

    • Clinics

    • Retail Pharmacy

    • Online Pharmacy

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Diabetic Neuropathy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Diabetic Neuropathy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Diabetic Neuropathy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Diabetic Neuropathy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Diabetic Neuropathy Market Analysis and Outlook to 2022

    • 7.1 Global Diabetic Neuropathy Consumption (2017-2022)

    • 7.2 United States Diabetic Neuropathy Consumption (2017-2022)

    • 7.3 Europe Diabetic Neuropathy Consumption (2017-2022)

    • 7.4 China Diabetic Neuropathy Consumption (2017-2022)

    • 7.5 Japan Diabetic Neuropathy Consumption (2017-2022)

    • 7.6 India Diabetic Neuropathy Consumption (2017-2022)

    • 7.7 South Korea Diabetic Neuropathy Consumption (2017-2022)

    8 Region and Country-wise Diabetic Neuropathy Market Analysis and Outlook to 2028

    • 8.1 Global Diabetic Neuropathy Consumption Forecast (2022-2028)

    • 8.2 United States Diabetic Neuropathy Consumption Forecast (2022-2028)

    • 8.3 Europe Diabetic Neuropathy Consumption Forecast (2022-2028)

    • 8.4 China Diabetic Neuropathy Consumption Forecast (2022-2028)

    • 8.5 Japan Diabetic Neuropathy Consumption Forecast (2022-2028)

    • 8.6 India Diabetic Neuropathy Consumption Forecast (2022-2028)

    • 8.7 South Korea Diabetic Neuropathy Consumption Forecast (2022-2028)

    9 Global Diabetic Neuropathy Market Outlook by Types and Applications to 2022

    • 9.1 Global Diabetic Neuropathy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Peripheral Neuropathy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Autonomic Neuropathy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Proximal Neuropathy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Focal Neuropathy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Diabetic Neuropathy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Global Diabetic Neuropathy Market Outlook by Types and Applications to 2028

    • 10.1 Global Diabetic Neuropathy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Peripheral Neuropathy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Autonomic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Proximal Neuropathy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Focal Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Diabetic Neuropathy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    11 Global Diabetic Neuropathy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Diabetic Neuropathy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Diabetic Neuropathy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Diabetic Neuropathy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Diabetic Neuropathy Market Competitive Analysis

    • 14.1 Eli Lilly and Company

      • 14.1.1 Eli Lilly and Company Company Details

      • 14.1.2 Eli Lilly and Company Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly and Company Diabetic Neuropathy Product and Service

    • 14.2 Pfizer Inc

      • 14.2.1 Pfizer Inc Company Details

      • 14.2.2 Pfizer Inc Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Inc Diabetic Neuropathy Product and Service

    • 14.3 NeuroMetrix

      • 14.3.1 NeuroMetrix Company Details

      • 14.3.2 NeuroMetrix Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 NeuroMetrix Diabetic Neuropathy Product and Service

    • 14.4 Cephalon Inc

      • 14.4.1 Cephalon Inc Company Details

      • 14.4.2 Cephalon Inc Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Cephalon Inc Diabetic Neuropathy Product and Service

    • 14.5 Janssen Pharmaceuticals, Inc

      • 14.5.1 Janssen Pharmaceuticals, Inc Company Details

      • 14.5.2 Janssen Pharmaceuticals, Inc Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Janssen Pharmaceuticals, Inc Diabetic Neuropathy Product and Service

    • 14.6 GlaxoSmithKline

      • 14.6.1 GlaxoSmithKline Company Details

      • 14.6.2 GlaxoSmithKline Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GlaxoSmithKline Diabetic Neuropathy Product and Service

    • 14.7 ACTAVIS

      • 14.7.1 ACTAVIS Company Details

      • 14.7.2 ACTAVIS Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 ACTAVIS Diabetic Neuropathy Product and Service

    • 14.8 Johnson and Johnson

      • 14.8.1 Johnson and Johnson Company Details

      • 14.8.2 Johnson and Johnson Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Johnson and Johnson Diabetic Neuropathy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Diabetic Neuropathy

    • Figure Diabetic Neuropathy Picture

    • Table Global Diabetic Neuropathy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diabetic Neuropathy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diabetic Neuropathy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Diabetic Neuropathy Consumption by Country (2017-2022)

    • Figure United States Diabetic Neuropathy Consumption and Growth Rate (2017-2022)

    • Table Europe Diabetic Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure China Diabetic Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Japan Diabetic Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure India Diabetic Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Diabetic Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetic Neuropathy Consumption Forecast by Country (2022-2028)

    • Figure United States Diabetic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Diabetic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Diabetic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Diabetic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Diabetic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Diabetic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peripheral Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Autonomic Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Proximal Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Focal Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Peripheral Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autonomic Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Proximal Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Focal Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Diabetic Neuropathy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Diabetic Neuropathy Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Diabetic Neuropathy Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Diabetic Neuropathy Product and Service

    • Table NeuroMetrix (Foundation Year, Company Profile and etc.)

    • Table NeuroMetrix Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeuroMetrix Diabetic Neuropathy Product and Service

    • Table Cephalon Inc (Foundation Year, Company Profile and etc.)

    • Table Cephalon Inc Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cephalon Inc Diabetic Neuropathy Product and Service

    • Table Janssen Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals, Inc Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals, Inc Diabetic Neuropathy Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Diabetic Neuropathy Product and Service

    • Table ACTAVIS (Foundation Year, Company Profile and etc.)

    • Table ACTAVIS Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table ACTAVIS Diabetic Neuropathy Product and Service

    • Table Johnson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Diabetic Neuropathy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Diabetic Neuropathy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US